Search Results - Michael Herdman
You must be logged in first
- Showing 1 - 11 results of 11
-
1
-
2
-
3
-
4
-
5
Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L by Michael Herdman, Cicely Kerr, Marco Pavesi, Jamie Garside, Andrew Lloyd, Patricia Cubi-Molla, Nancy Devlin
Published 2020-03-01
Article -
6
Desarrollo de la versión en español del KIDSCREEN: un cuestionario de calidad de vida para la población infantil y adolescente Development of the Spanish version of the KIDSCREEN:... by Marta Aymerich, Silvina Berra, Imma Guillamón, Michael Herdman, Jordi Alonso, Ulrike Ravens-Sieberer, Luis Rajmil
Published 2005-04-01
Article -
7
ADAPTACI N AL ESPA OL DEL CUESTIONARIO VEC ET SANTE PER UE DE L ADOLESCENT (VSP-A): UNA MEDIDA GEN RICA DE CALIDAD DE VIDA PARA ADOLESCENTES by Vicky Serra-Sutton, Michael Herdman, Luis Rajmil, Rosalía Santed, Montse Ferrer, Pascal Auquier, Marie Claude Siméoni
Published 2002-01-01
Article -
8
An exploratory, large-scale study of pain and quality of life outcomes in cancer patients with moderate or severe pain, and variables predicting improvement. by Constanza Maximiano, Iker López, Cristina Martín, Luis Zugazabeitia, Juan L Martí-Ciriquián, Miguel A Núñez, Jorge Contreras, Michael Herdman, Susana Traseira, Mariano Provencio
Published 2018-01-01
Article -
9
Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAI... by Nancy Devlin, Michael Herdman, Marco Pavesi, De Phung, Shevani Naidoo, Tomasz M. Beer, Bertrand Tombal, Yohann Loriot, Cristina Ivanescu, Teresa Parli, Mark Balk, Stefan Holmstrom
Published 2017-06-01
Article -
10
Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates. by Susan B Laffan, Andrew S Thomson, Shing Mai, Cindy Fishman, Takahito Kambara, Kiran Nistala, James T Raymond, Shugui Chen, Thulasi Ramani, Laura Pageon, Rodd Polsky, Mark Watkins, Gemma Ottolangui, John R White, Curtis Maier, Michael Herdman, Gerben Bouma
Published 2020-01-01
Article -
11
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome by Xavier Mariette, Francesca Barone, Chiara Baldini, Hendrika Bootsma, Kenneth L. Clark, Salvatore De Vita, David H. Gardner, Robert B. Henderson, Michael Herdman, Karoline Lerang, Prafull Mistry, Raj Punwaney, Raphaele Seror, John Stone, Paul L.A. van Daele, André van Maurik, Nicolas Wisniacki, David A. Roth, Paul Peter Tak
Published 2022-12-01
Article